Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Xellia buys ex-Ben Venue site and aims to restart production in 2017

Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.

FDA warning for Sandoz after data and training issues at Indian plants

Manipulated employee records and English-only training materials were among violations cited by the US FDA at two Indian plants, but Sandoz is confident these will be resolved.

Seaweed shortage prompts Thermo to suspend sale of two lab agars

Thermofisher Scientific has stopped selling two agars used in pharmaceutical industry control labs, citing a worldwide shortage of the seaweed used to make them.

Eisai to sell clinical diagnostics supply business

Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).

EC mulls changes to Orphan Drug rules

Tweaks to EU orphan drug rules (OD) may be needed to accommodate Ebola treatment development and block industry attempts to delay generic entry says the European Commission.

AZ not worried about giving Sanofi a potential blockbuster in swap deal

AstraZeneca says it had no worries about giving rival Sanofi a potential blockbuster drug when the two exchanged compound library molecules this month. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...